A take on the Blanco Report https://www.stockgumshoe.com/reviews/...alert/...ray-blancos.../comment-page-1/
1 day ago - Ray Blanco calls their technology a “revolutionary 'prion targeting' protocol,” and these are the hints he drops about the company: “A scientific breakthrough so ... This is, Thinkolator sez, the little Canadian biotech ProMIS Neurosciences (PMN in Toronto, ARFXF OTC in the US). And I'm not going to dig ...
I found this article interesting on three accounts
He actually names ProMis which was pretty obvious -------."So who is it? This is, Thinkolator sez, the little Canadian biotech ProMIS Neurosciences (PMN in Toronto, ARFXF OTC in the US)."
He suggest what the FEB 14 date maybe about. "So yes, the company will likely have a quarterly report around February 14, but the most aggressive thing likely from that is some update to their timeline for applying to start Phase 1 trials (the IND application) at some point over the next year or so, or, perhaps some optimistic commentary about partnering with a larger company."
He closed the article with. " P.S. This isn’t the first time Blanco’s attention has been poured on an Alzheimer’s Disease stock — back in 2015 his teaser ad promises of a breakthrough, similar in tone to this ad, helped Anavex (AVXL) go from $5 to $15 in a matter of a week or so, though it came sharply back down when the reality of long-term clinical trials hit the stock. AVXL was far more advanced, of course, they were in Phase 2 trials at the time."
Just some thoughts to ponder. Hoping Feb 14 is significant and not just BS from Blanco
glta J